focus -WSS

focus

author：entertainment 2025-09-28 01:36:34 - browse：2

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Readout LOUD podcast: Live from STAT Breakthrough Summit West

hotspot

WSS

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Surprise medical billing ban raises prices elsewhere

Reporting on presidential health from Reagan to Trump and Biden

Abridge raises $150m as clinical notes automation market heats up

NVIDIA and Google execs on the future of AI and drug discovery

Second House panel advances two

leisure time

focus

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

As AI regulations shape up, health tech startups beg for clarity

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Measles policy set amid Florida outbreak alarms vaccine proponents

At least 13 dead in Texas as scorching temps continue

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: Live from STAT Breakthrough Summit West

The high cost of giving birth even with insurance

Military medical care influenced by rank and race, new study finds

focus

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Second House panel advances two

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Weight loss drugs aren’t covered by Obamacare. That may change

WATCH: Why do our ears pop?

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

explore

focus

hotspot

hotspot